Phase II trial of 6-thioguanine administered as 120 hour continuous infusion for refractory or recurrent small cell lung cancer
Year: 1993
Type: article
Study design: Clinical Trial
Source: Investigational New Drugs
DOI: 10.1007/bf00873917
Language: English
Topic: Lung Cancer Research Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2316559691
